🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Although ACTHAR gel is approved for the treatment of acute relapses, it is ...
Status
Unknown
Location
Icahn School of Medicine at Mount Sinai
Start Date
2013-07
Trial ID
NCT01900093
Treatments Being Tested
This Phase 4 study is being performed to examine the effects of Acthar for ...
Status
Completed
Location
Mallinckrodt Investigational Site
Start Date
2013-01
Trial ID
NCT01753401
Treatments Being Tested
Systemic lupus erythematosus is a serious and potentially life-threatening ...
Status
Completed
Location
Justus J. Fiechtner
Start Date
2012-10
Trial ID
NCT01769937
Treatments Being Tested
This is a randomized study exploring the efficacy, safety and steroid spari...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02779153
Treatments Being Tested
West syndrome (WS) is a specific type of epilepsy (or seizure disorder) tha...
Status
Terminated
Location
Ann & Robert H. Lurie Children's Hospital of Chicago
Start Date
2011-07
Trial ID
NCT01367964
Treatments Being Tested
Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar...
Status
Completed
Location
Toyos Clinic
Start Date
2018-07-01
Trial ID
NCT03287635
Treatments Being Tested
There is a need for a more reliable, expeditious therapy that can be used a...
Status
Withdrawn
Location
Cleveland Clinic Main Campus
Start Date
2019-02-01
Trial ID
NCT02920710
Treatments Being Tested
Treatment with ACTHAR Gel will result in a reduction of ocular inflammation...
Status
Completed
Location
Cleveland Clinical Foundation
Start Date
2016-07
Trial ID
NCT02725177
Treatments Being Tested
The purpose of this study is to find out if Acthar Gel is safe and effectiv...
Status
Completed
Location
UAB Lung Health Center
Start Date
2018-02-21
Trial ID
NCT03320070
Treatments Being Tested
ACTHAR is a FDA approved drug for MS relapses. The purpose of the study is ...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12-20
Trial ID
NCT03021317
Treatments Being Tested